Final Survival Analysis of ROSE/TRIO-012
J Clin Oncol
.
2016 Oct 20;34(30):3714-3715.
doi: 10.1200/JCO.2016.68.9182.
Authors
John R Mackey
1
,
Nicole McCarthy
2
,
Karen A Gelmon
3
,
Sunil Verma
4
,
Rodrigo Fresco
5
,
Francois Thireau
6
,
Helena Fung
7
,
Miguel Martín
8
Affiliations
1
Cross Cancer Institute, Edmonton, Alberta, Canada.
2
ICON Cancer Care Wesley, Brisbane, Queensland, Australia.
3
BC Cancer Agency, Vancouver, British Columbia, Canada.
4
Tom Baker Cancer Centre, Calgary, Alberta, Canada.
5
Translational Research in Oncology, Montevideo, Uruguay.
6
Translational Research in Oncology, Paris, France.
7
Translational Research in Oncology, Edmonton, Alberta, Canada.
8
Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain.
PMID:
27480148
DOI:
10.1200/JCO.2016.68.9182
No abstract available